Drug stocks feel the heat
14335
Drug stocks took another hit Friday, a day after a veteran Food and Drug Administration researcher said that five drugs currently on the market needed closer scrutiny for possible safety risks.
355594
The stock's case of ennui isn't over yet.
328188
Drug stocks continued to slide on the week toward new 52-week lows as a few bright spots were eclipsed by losses in large-cap stocks.
203976
News of the connection between Celebrex and increased heart risk reached Wall Street only moments before the market opened Friday.
753455
Pfizer to investors: Don't stop believing.
642692
The stock will continue to be depressed, but things will improve if Celebrex's safety is proven.
140996
A day late and possibly several millions of dollars short. That's the scenario facing one drug manufacturer unless it can get a helping hand from Congress.
363785
Sales of the multiple sclerosis drug are picking up, but probably can't grow into the stock's valuation.
444667
Pfizer&#39;s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors&#39; concerns over the pharmaceutical sector.
602322
Bargain hunters may want to keep an eye on this stock.
331175
Several hot drugs are generating smoking returns.
131381
Uncertainty is spreading like a cancer in the pharmaceutical investing world, and that&#39;s bad news for the segment&#39;s kingpin, Pfizer (NYSE: PFE).
243734
With M&A fever hitting new highs, we ponder which deals will work out.
386065
U.S. stocks cut some losses late  Friday afternoon as investors did some bargain hunting for drug  stocks, which were beaten down to relatively cheap prices after  a slew of negative reports earlier in the day.
387905
The beleaguered drug giant&#39;s lowered forecast isn&#39;t as bad as Wall Street expected. But investors still await the long-term prognosis.
87694
FDA clearance sends stock skyrocketing.
758212
As Pfizer&#39;s (PFE:NYSE - news - research) Celebrex safety hiccup was unfolding Friday, I had a running conversation with a fund manager.